Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta 1a injection in a multiple sclerosis patient

Ozden, MG; Erel, A; ERDEM, OSMAN; Oztas, MURAT

doi:10.1111/j.1468-3083.2004.01086.x

Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta 1a injection in a multiple sclerosis patient

Atıf İçin Kopyala

Ozden M., Erel A., ERDEM O. A., Oztas M. O.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, cilt.19, sa.1, ss.112-113, 2005 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 1
Basım Tarihi: 2005
Doi Numarası: 10.1111/j.1468-3083.2004.01086.x
Dergi Adı: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.112-113
Anahtar Kelimeler: interferon-beta 1a, multiple sclerosis, skin lesions, BETA INJECTIONS
Gazi Üniversitesi Adresli: Evet

Özet

The most commonly reported side-effects of recombinant interferon-1betaa and 1b include local inflammatory injection site reactions, headache, fever, myalgia and a flu-like syndrome. In this case report, we describe the occurrence of cutaneous necrosis and dermal fibrosis following intramuscular interferon-pla injections in a multiple sclerosis patient.